{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-189435","form_type":"8-K","ticker":"VOR","cik":"0001817229","company_name":"Vor Biopharma Inc.","filed_at":"2025-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.100784+00:00","generated_at":"2026-05-17T09:46:03.667603+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Vor Biopharma announces three director resignations, appoints Sarah Reed","bullets":["Joshua Resnick, Matthew Patterson, and David Lubner resigned from the Board effective Aug 25-26, 2025; no disagreement cited.","Sarah Reed, General Counsel of RA Capital Management, appointed as independent Class II director effective Aug 27.","Reed receives standard compensation: $40k cash retainer, option to purchase 60k shares, and annual option grants.","Appointment was per securities purchase agreement with RA Capital, which holds >5% of VOR voting stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-189435","json":"https://secwatch.observer/filing/0001193125-25-189435.json","markdown":"https://secwatch.observer/filing/0001193125-25-189435.md","text":"https://secwatch.observer/filing/0001193125-25-189435.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525189435/0001193125-25-189435-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525189435/d939901d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:46:03.667603+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}